These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19303984)

  • 21. Sinusoidal dilation increases the risk of complications in hepatectomy for CRCLM - Protective effect of bevacizumab and diabetes mellitus, serum gamma-glutamyltranspeptidase as predictive factor.
    Martins J; Alexandrino H; Oliveira R; Cipriano MA; Falcão D; Ferreira L; Martins R; Serôdio M; Martins M; Tralhão JG; Prado e Castro L; Castro E Sousa F
    Eur J Surg Oncol; 2016 May; 42(5):713-21. PubMed ID: 26972374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity.
    Pilgrim CH; Satgunaseelan L; Pham A; Murray W; Link E; Smith M; Usatoff V; Evans PM; Banting S; Thomson BN; Phillips WA; Michael M
    HPB (Oxford); 2012 May; 14(5):333-40. PubMed ID: 22487071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy, liver injury, and postoperative complications in colorectal liver metastases.
    Makowiec F; Möhrle S; Neeff H; Drognitz O; Illerhaus G; Opitz OG; Hopt UT; zur Hausen A
    J Gastrointest Surg; 2011 Jan; 15(1):153-64. PubMed ID: 21061183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy-associated liver injury and its influence on outcome after resection of colorectal liver metastases.
    Reissfelder C; Brand K; Sobiegalla J; Rahbari NN; Bork U; Schirmacher P; Büchler MW; Weitz J; Koch M
    Surgery; 2014 Feb; 155(2):245-54. PubMed ID: 24314883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?
    Abdalla EK; Vauthey JN
    Dig Surg; 2008; 25(6):421-9. PubMed ID: 19212114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases.
    Zhao J; van Mierlo KMC; Gómez-Ramírez J; Kim H; Pilgrim CHC; Pessaux P; Rensen SS; van der Stok EP; Schaap FG; Soubrane O; Takamoto T; Viganò L; Winkens B; Dejong CHC; Olde Damink SWM;
    Br J Surg; 2017 Jul; 104(8):990-1002. PubMed ID: 28542731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
    Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
    Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation.
    Agostini J; Benoist S; Seman M; Julié C; Imbeaud S; Letourneur F; Cagnard N; Rougier P; Brouquet A; Zucman-Rossi J; Laurent-Puig P
    J Hepatol; 2012 Apr; 56(4):869-76. PubMed ID: 22200551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases.
    Morris-Stiff G; Tan YM; Vauthey JN
    Eur J Surg Oncol; 2008 Jun; 34(6):609-14. PubMed ID: 17764887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases.
    Blazer DG; Kishi Y; Maru DM; Kopetz S; Chun YS; Overman MJ; Fogelman D; Eng C; Chang DZ; Wang H; Zorzi D; Ribero D; Ellis LM; Glover KY; Wolff RA; Curley SA; Abdalla EK; Vauthey JN
    J Clin Oncol; 2008 Nov; 26(33):5344-51. PubMed ID: 18936472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted molecular therapies (cetuximab and bevacizumab) do not induce additional hepatotoxicity: preliminary results of a case-control study.
    Pessaux P; Panaro F; Casnedi S; Zeca I; Marzano E; Bachellier P; Jaeck D; Chenard MP
    Eur J Surg Oncol; 2010 Jun; 36(6):575-82. PubMed ID: 20452168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
    Rubbia-Brandt L; Audard V; Sartoretti P; Roth AD; Brezault C; Le Charpentier M; Dousset B; Morel P; Soubrane O; Chaussade S; Mentha G; Terris B
    Ann Oncol; 2004 Mar; 15(3):460-6. PubMed ID: 14998849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases.
    Ribero D; Wang H; Donadon M; Zorzi D; Thomas MB; Eng C; Chang DZ; Curley SA; Abdalla EK; Ellis LM; Vauthey JN
    Cancer; 2007 Dec; 110(12):2761-7. PubMed ID: 17960603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases.
    Fernandez FG; Ritter J; Goodwin JW; Linehan DC; Hawkins WG; Strasberg SM
    J Am Coll Surg; 2005 Jun; 200(6):845-53. PubMed ID: 15922194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.
    Vauthey JN; Pawlik TM; Ribero D; Wu TT; Zorzi D; Hoff PM; Xiong HQ; Eng C; Lauwers GY; Mino-Kenudson M; Risio M; Muratore A; Capussotti L; Curley SA; Abdalla EK
    J Clin Oncol; 2006 May; 24(13):2065-72. PubMed ID: 16648507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy-induced splenic volume increase is independently associated with major complications after hepatic resection for metastatic colorectal cancer.
    Simpson AL; Leal JN; Pugalenthi A; Allen PJ; DeMatteo RP; Fong Y; Gönen M; Jarnagin WR; Kingham TP; Miga MI; Shia J; Weiser MR; D'Angelica MI
    J Am Coll Surg; 2015 Mar; 220(3):271-80. PubMed ID: 25617913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Chemotherapy-associated steatohepatitis in patients with colorectal cancer and surgery on hepatic metastasis: clinical validation of a histopathological scoring system and preoperative risk assessment].
    Kampfenkel T; Tischoff I; Bonhag H; Eckardt M; Schmiegel W; Tannapfel A; Reinacher-Schick A; Viebahn R
    Z Gastroenterol; 2011 Oct; 49(10):1407-11. PubMed ID: 21964894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM).
    Saez-Carlin P; García-Botella A; Diez-Valladares LI; Ortega Medina L; Méndez R; González JCM; Bernal I; Serrano García I; Avellana R; Torres García AJ
    Clin Transl Oncol; 2020 Jul; 22(7):1180-1186. PubMed ID: 31758496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy.
    Nishigori N; Matsumoto M; Koyama F; Hayakawa M; Hatakeyayama K; Ko S; Fujimura Y; Nakajima Y
    PLoS One; 2015; 10(11):e0143136. PubMed ID: 26580395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.
    Nakano H; Oussoultzoglou E; Rosso E; Casnedi S; Chenard-Neu MP; Dufour P; Bachellier P; Jaeck D
    Ann Surg; 2008 Jan; 247(1):118-24. PubMed ID: 18156931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.